Showing results (201-210 of 330) with videos related to

Sort By:
Pageof 33
Thrombosis and Haemostasis|October 1, 1996
Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1R Schneppenheim, U Budde, S Krey, et al.
Hamostaseologie|November 11, 2014
Inhibitor development and management in three non-severe haemophilia A patients with T295A variantV Ivaskevicius, G Goldmann, S Horneff, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 25, 2016
Efficacy and safety of BAY 81-8973, a full-length recombinant factor VIII: results from the LEOPOLD I trialK Saxena, S Lalezari, J Oldenburg, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|December 4, 2014
Controlled, cross-sectional MRI evaluation of joint status in severe haemophilia A patients treated with prophylaxis vs. on demandJ Oldenburg, R Zimmermann, O Katsarou, et al.
Hamostaseologie|November 11, 2014
Elective total knee arthroplasty in haemophilic patients. Proposal for a clinical pathwayT A Wallny, A C Strauss, G Goldmann, et al.
Hamostaseologie|November 6, 2015
Novel point mutation in fibrinogen (Innsbruck; BβArg44Gly). Phenotypic differences compared to another mutation (fibrinogen Nijmegen) at the same positionP Würtinger, A Griesmacher, V Ivaškevičius, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|January 26, 2008
Heterozygous large deletions of Factor 8 gene in females identified by multiplex PCR-LCA Pavlova, T Förster, D Delev, et al.
Hamostaseologie|January 18, 2019
Impact of Telemedicine Tools on Record Keeping and Compliance in Haemophilia CareA Banchev, G Goldmann, N Marquardt, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|March 3, 2016
Safety and efficacy of BAY 81-8973 for surgery in previously treated patients with haemophilia A: results of the LEOPOLD clinical trial programmeJ Oldenburg, J Windyga, K Hampton, et al.
Blood|October 7, 2000
De novo factor VIII gene intron 22 inversion in a female carrier presents as a somatic mosaicismJ Oldenburg, S Rost, O El-Maarri, et al.
Pageof 33